None listed
Conditions
Interventions
None listed
Sponsors
Yonsei University Health System, Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subjects aged more than 20 years old 2) Subjects with type 2 diabetes who were on sulphonylurea for glucose control i) more than 7.5% A1c level at the time of enrollment 3) Subjects who have willingness to keep the protocl 4) Subjects who consent in written form
Exclusion criteria
Exclusion criteria: 1) Cancer patients who currently on or will be scheduled for chemotherapy or radition therapy within 6 months. 2) Subjects with renal failure who currently on or will be scheduled for hemodialyisis therapy within 6 months 3) Subjects with heart failure (more than NYHA stage 3) Subjects with liver failure (more than Child-Pugh class B) 4) Gestational diabetes, type 1 diabetes and secondary yperglycemia, such as iatrogenic,inflammatory, or endocrine disorders, and liver cirrhosis. 5) Subjects who do not consent the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pattern of changes in spilt dose of total insulin | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes of HbA1c | — |
Countries
Korea, Republic of
Contacts
Public ContactHea Jin Kwon
Yonsei University Health System, Severance Hospital
Outcome results
None listed